AstraZeneca (AZN) Stock: Buy, Sell, or Hold?
$184.45
+0.07 (+0.04%)
▲
5d:
-1.06%
30d:
+10.66%
90d:
+17.57%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
37/100
Position
EXTENDED
30-Day Fair Range
$161.35 – $184.16
Position: EXTENDED
Forward P/E & Valuation
16.3x
CHEAP
vs 23.5x historical avg
Wall Street Target
$208.08
+12.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$181.20 / $192.65
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: AZN shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When AZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$388.32
Based on 7.9% avg growth
INTRINSIC VALUE TODAY
$241.11
23.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AZN is currently trading at $184.45, which is considered extended relative to its 30-day fair value range of $161.35 to $184.16. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.3) compared to its historical average (23.5). Remarkably, the market is currently pricing in an annual earnings decline of 11.5% over the next few years. This pessimistic expectation contrasts with the company's recent 23.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AZN is in a strong uptrend. The price is currently testing key support at $181.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AZN scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $208.07 (+12.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AZN is in a strong uptrend. The price is currently testing key support at $181.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AZN scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $208.07 (+12.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$161.35 -
$184.16
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.2%
Trading Range & Key Levels
30-Day Trading Range
$161.35 -
$184.16
Current vs Trading Range
EXTENDED
Support Level
$181.20
Resistance Level
$192.65
Current Trend
Strong Uptrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (23/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($208.07)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
16.30
Wall Street Target
$208.08
(+12.8%)
Revenue Growth (YoY)
6.7%
Earnings Growth (YoY)
23.5%
Profit Margin
17.7%
Valuation Discount vs History
-11.5% cheaper
PE vs Historical
16.3 vs 23.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.5%
(market-implied from PE analysis)
1-Year Target
$166.00
(-10%)
2-Year Target
$149.40
(-19%)
3-Year Target
$134.46
(-27%)
3-Yr Target (if PE normalizes)
(PE: 16→24)
$193.87
(+5%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 11.8%)
$314.28
(+70%)
Base:
(SPY PE: 16.3, Growth: 11.8%)
$257.93
(+40%)
Bear:
(PE: 13.9, Growth: 11.8%)
$219.24
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 26.08 | Current EPS (TTM): $7.07
Bull Case
$324.64
(+76%)
Analyst growth 60.1%, PE expands to 28.7
Base Case
$295.13
(+60%)
Market implied 60.1%, PE stable at 26.1
Bear Case
$125.38
(-32%)
Severe decline -20.0%, PE contracts to 22.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.3 to 23.5
Stabilization Target:
$265.94
(+44.2%)
PE Expansion Potential:
+44.2%
Share AZN Analysis
Share this live AZN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AZN)
Bullish
1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Sep 17, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on AZN are bullish (sentiment score +0.01) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 5:44 AM ET
Data refreshes hourly during market hours. Next update: 6:44 AM
Data refreshes hourly during market hours. Next update: 6:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AZN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1453 | 39 SELL |
|
ABBV
AbbVie Inc |
STRONG BUY
29 analysts |
$306 | 49 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$175 | 47 HOLD |
|
MRK
Merck & Company Inc |
BUY
28 analysts |
$162 | 53 HOLD |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$266 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive AZN Research Pages
